Patents by Inventor Hideo Tsukada

Hideo Tsukada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090163461
    Abstract: The present invention provides a novel compound represented by the formula (I): wherein R1 and R2 are as defined in the specification, or a salt thereof, which is useful as a reagent (radiotracer) for VAChT mapping and the like, and can be used for positron emission tomography (PET), and a production method of the compound. Moreover, the present invention provides a diagnostic reagent for diagnosing cholinergic neurodegenerative disorders (e.g., Alzheimer's disease, memory disorder, learning disorder, schizophrenia, cognitive dysfunction, hyperactivity disorder, anxiety neurosis, depression, analgia, Parkinson's disease and the like) and the like, which contains the aforementioned compound.
    Type: Application
    Filed: March 31, 2006
    Publication date: June 25, 2009
    Inventors: Kazuhiro Shiba, Kiichi Ishiwata, Hideo Tsukada, Shingo Nishiyama
  • Publication number: 20090098048
    Abstract: It is intended to provide a radioactive tyrosine derivative represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein R1 represents a group selected from the group consisting of —11CH3, —11CH2CH3, —CH218F, and —CH2CH2CH218F.
    Type: Application
    Filed: March 11, 2008
    Publication date: April 16, 2009
    Applicant: HAMAMATSU PHOTONICS K.K.
    Inventors: Kengo SATO, Hideo TSUKADA
  • Publication number: 20090087378
    Abstract: It is an objective of the present invention to provide a positron tomography method applicable to the diagnosis of specific brain diseases and to provide a positron-emitting compound for use in the method. The present invention method relates to a positron tomography method for measuring a distribution and concentration of a positron-emitting source, and is characterized in using the compound (I) as the positron-emitting source.
    Type: Application
    Filed: February 16, 2007
    Publication date: April 2, 2009
    Applicant: NARD INSTITUTE, LTD.
    Inventors: Masaaki Matsuo, Takeru Kitashoji, Tatsuhiro Kobashi, Makoto Takahagi, Hideo Tsukada, Shingo Nishiyama
  • Patent number: 7191109
    Abstract: In a PET apparatus 1, in a calculation processing unit 50, for each frame, radiation data for a region of interest K of a measurement-subjected part H is extracted, and then the optimum administration rate of a labeled substance T is calculated based on the radiation data such that the radiation concentration for the region of interest K will be steady regardless of the physiological state (blood flow rate etc.) of the subject S. In an administration rate control unit 60, feedback control of the administration rate of the labeled substance into the subject S is carried out based on the calculated optimum administration condition. As a result, the change in the amount accumulated of the labeled substance T in the region of interest K between before and after administration of a drug being tested Y can be obtained easily and precisely in real time as the amount of change in the radiation concentration, and it becomes possible to grasp the measurement results rapidly and easily.
    Type: Grant
    Filed: January 29, 2001
    Date of Patent: March 13, 2007
    Assignee: Hamamatsu Photonics K.K.
    Inventors: Hiroyuki Ohba, Hideo Tsukada
  • Patent number: 6649142
    Abstract: A muscarinic acetylcholine nervous system labeled compound for positron emission tomography measurement of the present invention has a structure represented by undermentioned general formula (I): [in the formula, W represents one selected from the group consisting of groups represented by undermentioned formulae (II) and (III): (in the formulae, R represents one selected from the group consisting of an 11C-labeled ethyl group and an 11C-labeled propyl group), and in the case that W is a group represented by above-mentioned formula (II), above-mentioned formula (I) is the (+)-isomer].
    Type: Grant
    Filed: October 18, 2002
    Date of Patent: November 18, 2003
    Assignee: Hamamatsu Photonics K.K.
    Inventors: Hideo Tsukada, Kengo Sato, Shingo Nishiyama, Norihiro Harada
  • Publication number: 20030113261
    Abstract: A muscarinic acetylcholine nervous system labeled compound for positron emission tomography measurement of the present invention has a structure represented by undermentioned general formula (I): 1
    Type: Application
    Filed: October 18, 2002
    Publication date: June 19, 2003
    Inventors: Hideo Tsukada, Kengo Sato, Shingo Nishiyama, Norihiro Harada
  • Publication number: 20030014132
    Abstract: In a PET apparatus 1, in a calculation processing unit 50, for each frame, radiation data for a region of interest K of a measurement-subjected part H is extracted, and then the optimum administration rate of a labeled substance T is calculated based on the radiation data such that the radiation concentration for the region of interest K will be steady regardless of the physiological state (blood flow rate etc.) of the subject S. In an administration rate control unit 60, feedback control of the administration rate of the labeled substance into the subject S is carried out based on the calculated optimum administration condition. As a result, the change in the amount accumulated of the labeled substance T in the region of interest K between before and after administration of a drug being tested Y can be obtained easily and precisely in real time as the amount of change in the radiation concentration, and it becomes possible to grasp the measurement results rapidly and easily.
    Type: Application
    Filed: August 6, 2002
    Publication date: January 16, 2003
    Inventors: Hiroyuki Ohba, Hideo Tsukada